| Subject: | FDA Guidance for Intra-Aortic Balloon Pumps |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Thu, 12 Jul 2007 - 06:00 am |
| The FDA has recently posted an article with tips for preventing problems with intra-aortic balloon pumps (IAPBs). Typically used as a treatment for refractory left ventricular heart failure, benefits seen with use of the IABP include increased cardiac output, coronary blood flow and systemic perfusion pressure and decreased afterload and myocardial oxygen demands. There are several device precautions that can be taken to reduce the possibility of an adverse event associated with... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
Customizable Documents and Tools:
Related MCN Products:
|
|
With over 20 years experience in regulatory compliance, MCN Healthcare brings you the most comprehensive regulatory compliance tool available. StayAlert! is the only comprehensive e-mail notification service available that not only notifies you of the changes in major federal regulations, but also provides the policies, procedures, tools and best practices to help you meet the changing regulation. StayAlert! actively monitors TJC (JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG and many others so you don't have to. Other vendors have components of legislated requirements available online or on CD-ROM. However there is no other product that marries regulatory agency mandates with implementation tools, making the latest compliance information immediately available online. No other product provides an interpretative analysis, followed by a practical application tool, therefore providing users with an immediate solution to compliance problems. StayAlert! includes operational components for healthcare organizations, allowing complete facility compliance with mandated requirements, online. |
|
